Elevated urinary IL-1β levels in multidrug resistant Escherichia coli and Klebsiella infections

Inflamm Res. 2020 Jan;69(1):11-13. doi: 10.1007/s00011-019-01304-1. Epub 2019 Dec 9.

Abstract

Introduction: Multidrug resistant (MDR) E. coli and Klebsiella infections are rising. IL-1β has been implicated in the differentiation of symptomatic and asymptomatic urinary tract infections, but its role in MDR infections has not been elucidated.

Material and methods: Urinary IL-1β levels were analysed by ELISA.

Results: Urinary IL-1β levels were statistically higher in patients with bacterial burden compared to controls and also in patients with MDR bacterial infections compared to those with multidrug-sensitive bacterial infections.

Conclusions: Urinary IL-1β levels might be a useful tool to identify patients with challenging MDR bacterial infections.

Keywords: E. coli; IL-1β; Klebsiella; Multidrug resistant; Urinary tract infections.

MeSH terms

  • Biomarkers / urine
  • Drug Resistance, Multiple, Bacterial*
  • Escherichia coli / growth & development
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / urine*
  • Humans
  • Interleukin-1beta / urine*
  • Klebsiella / growth & development
  • Klebsiella Infections / microbiology
  • Klebsiella Infections / urine*

Substances

  • Biomarkers
  • IL1B protein, human
  • Interleukin-1beta